Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts.
Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts.
复制标题
DOI:
10.1002/art.34336
复制
发表时间:
2012-06
影响因子:
--
通讯作者:
Koch, Alisa E.
中科院分区:
文献类型:
--
作者:
Tsou, Pei-Suen;Talia, Nadine N.;Pinney, Adam J.;Kendzicky, Ann;Piera-Velazquez, Sonsoles;Jimenez, Sergio A.;Seibold, James R.;Phillips, Kristine;Koch, Alisa E.
Platelet-derived growth factor (PDGF) and its receptor (PDGFR) promote fibrosis in scleroderma (SSc) dermal fibroblasts, which produce excessive reactive oxygen species (ROS). PDGFR is phosphorylated upon PDGF stimulation, and dephosphorylated by protein tyrosine phosphatases (PTPs), including PTP1B. In this study we determine whether the thiol-sensitive PTP1B is affected by ROS, thus enhancing PDGFR phosphorylation (p-PDGFR) and collagen I (Col I) synthesis. The effect of a thiol antioxidant, n-acetylcysteine (NAC), was also investigated. Fibroblasts were isolated from skin. A phosphate release assay was used for PTP1B activity. ROS and Col I were significantly higher in SSc fibroblasts, accompanied by significantly lower amounts of free thiols compared to normal fibroblasts. After PDGF stimulation, not only were the PDGFR and ERK1/2 phosphorylated to a greater extent, but the ability to produce PTP1B was also hampered in SSc fibroblasts. PTP1B activity was significantly inactivated in SSc fibroblasts, which resulted from cysteine oxidation by higher levels of ROS, since oxidation of multiple PTPs, including PTP1B, was observed. Decreased PTP1B expression in normal fibroblasts led to increased Col I. NAC restored the low PTP1B activity, improved the profile of p-PDGFR, decreased the numbers of tyrosine-phosphorylated proteins and Col I, and scavenged ROS in SSc fibroblasts. We introduce a new mechanism by which ROS promote a profibrotic phenotype in SSc fibroblasts through oxidative inactivation of PTP1B leading to pronounced PDGFR activation. Our study also provides a novel molecular mechanism by which NAC therapy may act on ROS and PTP1B to benefit SSc patients.
登录
查看更多内容
影响因子:
4.8
作者:
Kovalenko, M;Denner, K;Östman, A
通讯作者:
Östman, A
影响因子:
15.9
作者:
Kawaguchi, Y;Hara, M;Wright, TM
通讯作者:
Wright, TM
影响因子:
7.4
作者:
ARUOMA, OI;HALLIWELL, B;BUTLER, J
通讯作者:
BUTLER, J
DOI:
10.1161/01.atv.0000246777.30819.85
发表时间:
2006-12-01
影响因子:
8.7
作者:
Kappert, Kai;Sparwel, Jan;Ostman, Arne
通讯作者:
Ostman, Arne
影响因子:
4.3
作者:
Byon, JCH;Kusari, AB;Kusari, J
通讯作者:
Kusari, J